Antiseptics for treating infected wounds: Efficacy on biofilms and effect of pH

Critical Reviews in Microbiology

Volumn 42, Issue 2, 2016, Pages 293-309

  Percival, Steven L ^a   Finnegan, Simon ^b   Donelli, Gianfranco ^c   Vuotto, Claudia ^c   Rimmer, Steve ^b   Lipsky, Benjamin A ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antiseptics; biofilms; iodine; pH; silver

Indexed keywords

ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; CADEXOMER IODINE; CHLORHEXIDINE; EDETIC ACID; IODINE; IODOPHOR; OCTENIDINE; POLY(HEXAMETHYLENEBIGUANIDE); POVIDONE IODINE; QUATERNARY AMMONIUM DERIVATIVE; SILVER; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL GROWTH; BIOFILM; CANDIDA ALBICANS; CHRONIC WOUND; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG MECHANISM; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MEMBRANE DAMAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SILVER DRESSING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION; ANIMAL; BIOLOGICAL DRESSING; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; MICROBIOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BIOFILMS; BIOLOGICAL DRESSINGS; HUMANS; HYDROGEN-ION CONCENTRATION; IODINE; SILVER; TREATMENT OUTCOME; WOUND INFECTION;

EID: 84959306040     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2014.940495     Document Type: Review

References (246)

1. Ahlstrom B, Thompson RA, Edebo L. (1999). The effect of hydrocarbon chain length, pH and temperature on the binding and bactericidal effect of amphiphilic betaine esters on Salmonella typhimurium. APMIS 107:318-24.
2. Akiyama H, Oono T, Saito M, Iwatsuki K. (2004). Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy. J Dermatol 31: 529-34.
3. Al-Bakri AG, Othman G, Bustanji Y. (2009). The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents. J Appl Microbiol 107:280-6.
4. Amalaradjou MAR, Norris CE, Kumar V. (2009). Effect of octenidine hydrochloride on planktonic cells and biofilms of Listeria monocytogenes. Appl Environ Microbioly 75:4089-92.
5. Ames GF, Nikaido K, Groarke J, Petithory J. (1989). Reconstitution of periplasmic transport in inside-out membrane vesicles. Energization by ATP. Journal of Biological Chemistry 264:3998-4002.
6. Ammons MCB, Ward LS, James GA. (2011). Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings. International Wound Journal 8:268-73.
7. Apelqvist J, Ragnarson Tennvall G. (1996) Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial. Acta Derm Venereol 76:231-5.
8. Arzt H, Fromantin I, Ribinik P, et al. (2012). Which medical device and/or which local treatment are to be used, as of 2012, in patients with infected pressure sore? Developing French guidelines for clinical practice. Ann Phys Rehabil Med 55:498-507.
9. Babich H, Wurzburger BJ, Rubin YL, et al. (1995). An in vitro study on the cytotoxicity of chlorhexidine digluconate to human gingival cells. Cell Biol Toxicol 11:79-88.
10. Badawy EI, Luxton AM, Silva TP, et al. (2010). Impact of environmental conditions (pH, ionic strength, and electrolyte type) on the surface charge and aggregation of silver nanoparticles suspensions. Environ Sci Technol 44:260-6.
11. Bailey DM, De Grazia SJ, Hoff PL, et al. (1984). Bispyridinamines: a new class of topical antimicrobial agents as inhibitors of dental plaque. J Med Chem 27:1457-64.
12. Balin AK, Pratt L. (2002). Dilute povidone-iodine solutions inhibit human skin fibroblast growth. Dermatol Surg 28:210-14.
13. Balogh DM, Bauer JM, Anderl HH. (2004). Iodine resorption and excretion in Betaisodona® (Betadine®) treatment of extensive burns. Eur J Plastic Surg 5:127-34.
14. Banin E, Brady KM, Greenberg EP. (2006). Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72:2064-9.
15. Barbour ME, Maddocks SE, Wood NJ, Collins AM. (2013). Synthesis, characterization, and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products. Int J Nanomedicine 8:3507-19.
16. Basrani B, Lemonie C. (2005). Chlorhexidine gluconate. Aust Endod J 31:48-52.
17. Basrani B, Tjaderhane L, Santos JM, et al. (2003). Efficacy of chlorhexidine- and calcium hydroxide-containing medicaments against Enterococcus faecalis in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:618-24.
18. Baxter CR. (1994). Immunologic reactions in chronic wounds. Am J Surg 167:S12-14.
19. Bjarnsholt T, Kirketerp-Møller K, Kristiansen S. (2007a). Silver against Pseudomonas aeruginosa biofilms. APMIS 115:921-8.
20. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, et al. (2007b). Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16:2-10.
21. Block SS. (2001). Disinfection, sterilization and preservation. 5th ed. Philadelphia: Lippincott Williams & Wilkins.
22. Brennan SS, Leaper DJ. (1985). The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg 72:780-2.
23. Brook I. (1985). Role of encapsulated anaerobic bacteria in synergistic infections. Crit Rev Microbiol 14:171-93.
24. Brown ML, Aldrich HC, Gauthier JJ. (1995). Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms. Appl Environ Microbiol 61:187-93.
25. Burks RI. (1998). Povidone iodine solution in wound treatment. Phys Ther 78:212-18.
26. Butcher M. (2012). PHMB: an effective antimicrobial in wound bioburden management. Br J Nurs 21:S16, S18-21.
27. Cabral CT, Fernandes MH. (2007). In vitro comparison of chlorhexidine and povidone-iodine on the long-term proliferation and functional activity of human alveolar bone cells. Clin Oral Investig 11:155-64.
28. Campbell N, Campbell D. (2013). Evaluation of a non-adherent, povidone-iodine dressing in a case series of chronic wounds. J Wound Care 22:404-6.
29. Castellano JJ, Shafil SM, Ko F, et al. (2007). Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int Wound J 4: 114-22.
30. Chang Y, Gu W, McLandsborough L. (2012). Low concentration of ethylene diamine tetraacetic acid (EDTA) affects biofilm formation of Listeria monocytogenes by inhibiting its initial adherence. Food Microbiol 29:10-17.
31. Chang YC, Huang FM, Tai KW, Chou MY. (2001). The effect of sodium hypochlorite and chlorhexidine on cultured human periodontal ligament cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:446-50.
32. Chaw KC, Manimaran M, Tay FE. (2005). Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 49:4853-9.
33. Chen X, Schluesener HJ. (2008). Nanosilver: A nanoproduct in medical application. Toxicol Lett 176:1-12.
34. Chopra I. (2007). The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 59:587-90.
35. Clegg MS, Vertucci FJ, Walker C, et al. (2006). The effect of exposure to irrigant solutions on apical dentin biofilms in vitro. J Endod 32:434-7.
36. Cookson BD, Bolton MC, Platt JH. (1991). Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment. Antimicrob Agents Chemother 35: 1997-2002.
37. Cooper RA. (2007). Iodine revisited. Int Wound J 4:124-37.
38. Costerton JW, Stewart PS, Greenberg EP. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284:1318-22.
39. Cutting KF, Harding KG. (1994). Criteria to identify wound infection. J Wound Care 3:198-201.
40. Dai YY, Huang SK, Sharma JT, et al. (2010). Topical antimicrobials for burn wound infections. Recent Pat Antiinfect Drug Discov 5:124-51.
41. Danielsen L, Cherry GW, Harding K, Rollman O. (1997). Cadexomer iodine in ulcers colonised by Pseudomonas aeruginosa. J Wound Care 6:169-72.
42. Daróczy J. (2006). Quality control in chronic wound management: the role of local povidone-iodine (Betadine) therapy. Dermatol 212:82-7.
43. Davies GE, Francis J, Martin AR, et al. (1954). 1:6-di-40-chlorophenyldiguanidohexane ("Hibitane"). Laboratory investigation of a new antibacterial agent of high potency. Br J Pharmacol Chemother 9: 192-6.
44. Davis IJ, Richards H, Mullany P. (2005). Isolation of silver- and antibiotic-resistant Enterobacter cloacae from teeth. Oral Microbiol Immunol 20:191-4.
45. Davis SC, Ricotti C, Cazzaniga A, et al. (2008). Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Rep Regen 16:23-9.
46. De Saint Jean M, Brignole F, Bringuier A, et al. (1999). Effects of benzalkonium chloride on growth and survival of chang conjunctival cells invest. Ophthalmol. Vis Sci 40:619-30.
47. Denton GW. (1991). Chlorhexidine. In: Block SS, ed. Disinfection, Sterilization and preservation. 4th ed. Philadelphia: Lea & Febiger, 274-89.
48. Denyer SP, Stewart GSAB. (1998). Mechanisms of action of disinfectants. Int. Biodeterior. Biodegrad 41:261-8.
49. Devine DA, Percival RS, Wood DJ, et al. (2007). Inhibition of biofilms associated with dentures and toothbrushes by tetrasodium EDTA. J Appl Microbiol 103:2516-24.
50. Domagk G. (1935). A new class of disinfectants. Deut Med Wochschr 61:829-32.
51. Donelli G, Claudia V. (2014). Biofilm-based infections in long-term care facilities. Future Microbiol 9:175-88.
52. Dowd SE, Wolcott RD, Sun Y, et al. (2008). Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 3:e3326.
53. Eaglstein WH. (2008). Moist wound healing with occlusive dressings: a clinical focus. Dermatol Surg 27:175-82.
54. Fardal O, Turnbull RS. (1986). A review of the literature on use of chlorhexidine in dentistry. J Am Dent Assoc 112:863-9.
55. Ferguson JW, Hatton JF, Gillespie MJ. (2002). Effectiveness of intracanal irrigants and medications against the yeast Candida albicans. J Endod 28:68-71.
56. Foulkes DM. (1973). Some toxicological observations on chlorhexidine. J Periodontal Res Suppl 12:55-60.
57. Fumal I, Braham C, Pacquet P, et al. (2002). The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study. Dermatol 204:70-4.
58. Garcia-Fernandez MJ, Brackman G, Coenye T, et al. (2013). Antiseptic cyclodextrin-functionalized hydrogels and gauzes for loading and delivery of benzalkonium chloride. Biofouling 29:261-71.
59. Gethin G, Cowman S. (2006). Changes in Surface pH of chronic wounds when a honey dressing was used. Wounds UK Conference Proceedings; 2006 Nov 13-15; Wounds, Aberdeen, UK.
60. Giannelli M, Chellini F, Margheri M, et al. (2008). Effect of chlorhexidine digluconate on different cell types: a molecular and ultrastructural investigation. Toxicol In vitro 22:308-17.
61. Giaouris E, Chorianopoulos N, Doulgeraki A, Nychas GJ. (2013). Co-culture with listeria monocytogenes within a dual-species biofilm community strongly increases resistance of Pseudomonas putida to benzalkonium chloride. PloS One 8:772-6.
62. Gilbert P, Collier PJ, Brown, MR. (1990). Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother 34: 1865-8.
63. Gilbert P, Das J, Foley I. (1997). Biofilm susceptibility to antimicrobials. Adv Dent Res 11:160-7.
64. Gilbert P, Das JR, Jones MV, Allison DG. (2001). Assessment of resistance towards biocides following the attachment of micro-organisms to, and growth on, surfaces. J Appl Microbiol 91: 248-54.
65. Gilbert P, Pemberton D, Wilkinson DE. (1990). Synergism within polyhexamethylene biguanide biocide formulations. J Appl Bacteriol 69:593-8.
66. Gjødsbøl K, Christensen JJ, Karlsmark T, et al. (2006). Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 3:225-31.
67. Gomes BP, Vianna ME, Zaia AA, et al. (2013). Chlorhexidine in endodontics. Braz Dent J 24:89-102.
68. Gordon J. (1993). Clinical significance of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in UK hospitals and the relevance of povidone-iodine in their control. Postgrad Med J 69: 106-16.
69. Gottardi W. (1983). Chapter 8: iodine and iodine compounds. In: Block SS, ed. Disinfection, sterilization and preservation. 3rd ed. Philadelphia: Lea & Febiger, 183-96.
70. Gottardi W. (1985). The influence of the chemical behaviour of iodine on the germicidal action of disinfectant solutions containing iodine. J Hosp Infect 6:1-11.
71. Greenstein G, Jaffin RA, Hilsen KL, Berman CL. (1985). Repair of anterior gingival deformity with durapatite. A case report. J Periodontol 56:200-3.
72. Haefeli C, Franklin C, Hardy K. (1984). Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J Bacteriol 158:389-92.
73. Hamilton WA. (1968). The mechanism of the bacteriostatic action of tetrachlorosalicylanilide: a membrane-active antibacterial compound. J Gen Microbiol 50:441-58.
74. Hampton S. (2008). Malodorous fungating wounds: how dressings alleviate symptoms. Br J Community Nurs 13:S31-8.
75. Han KH, Maitra AK. (1989). Management of partial skin thickness burn wounds with inadine dressings. Burns 15:399-402.
76. Hansson C. (1988). The effects of cadexomer iodine paste in the treatment of venous leg ulcers compared with hydrocolloid dressing and paraffin gauze dressing. Int J Dermatol 37:390-6.
77. Harvey SC. (1985). Antiseptics and disinfectants. In: Gilman AG, Goodman LS, Rall TW, Murad F, eds. The pharmacological basis of therapeutics. 7th ed. New York: MacMillan Publishing, 974-7.
78. Heeg P. (1990). Antisepsis of mucous membranes: current status and aspects of future development. Z Gesamte Hyg 36:83-6.
79. Hill KE, Malic S, McKee R, et al. (2010). An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother 65:1195-206.
80. Hoffman KL, Han IY, Dawson PL. (2001). Antimicrobial effects of corn zein films impregnated with nisin, lauric acid, and EDTA. J Food Prot 64:885-9.
81. Hostýnek JJ, Hinz RS, Lorence CR, et al. (1993). Metals and the skin. Crit Rev Toxicol 23:171-235.
82. Houari A, Di Martino P. (2007). Effect of chlorhexidine and benzalkonium chloride on bacterial biofilm formation. Lett Appl Microbiol 45:652-6.
83. Howell-Jones RS, Wilson MJ, Hill KE, et al. (2005). A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 55:143-9.
84. Hübner NO, Matthes R, Koban I, et al. (2010). Efficacy of chlorhexidine, polihexanide and tissue-tolerable plasma against Pseudomonas aeruginosa biofilms grown on polystyrene and silicone materials. Skin Pharmacol Physiol 23:28-34.
85. Hugo WB. (1991). A brief history of heat and chemical preservation and disinfection. J Appl Bacteriol 71:9-18.
86. Ikeda T, Ledwith A, Bamford CH, Hann RA. (1984). Interaction of a polymeric biguanide biocide with phospholipids membranes. Biochim Biophys Acta 769:57-66.
87. Ioannou CJ, Hanlon GW, Denyer SP. (2007). Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus. Antimicrob Agents Chemother 51:296-306.
88. James GA, Swogger E, Wolcott R, et al. (2007). Biofilms in chronic wounds. Wound Repair Regen 16:37-44.
89. Jelenko 3rd C. (1969). Silver nitrate resistant E. Coli: report of case. Ann Surg 170:296-9.
90. Juda M, Paprota K, Jaloza D, et al. (2008). EDTA as a potential agent preventing formation of Staphylococcus epidermidis biofilm on polichloride vinyl biomaterials. Ann Agric Environ Med 15: 237-41.
91. Jung WK, Koo HC, Kim KW, et al. (2008). Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 74:2171-8.
92. Junka A, Bartoszewicz M, Smutnicka D, et al. (2013). Efficacy of antiseptics containing povidone-iodine, octenidine dihydrochloride and ethacridine lactate against biofilm formed by Pseudomonas aeruginosa and Staphylococcus aureus measured with the novel biofilm-oriented antiseptics test. Int Wound J.
93. Kim JH, Jin SG, Ku SK, et al. (2012). Wound healing evaluation of benzalkonium chloride-loaded hydrocolloid in the wound infection model. J Pharmal Invest 42:327-33.
94. Kim PJ, Attinger CE, Steinberg JS, et al. (2014). The impact of negativepressure wound therapy with instillation compared with standard negative-pressure wound therapy: a retrospective, historical, cohort, controlled study. Plast Reconstr Surg 133:709-16.
95. Kim PJ, Steinberg JS. (2012). Wound care: biofilm and it impact on the latest treatment modalities for ulcerations of the diabetic foot. Semin Vasc Surg 25:70-4.
96. Kingsley A, Tadej M, Colbourn A, et al. (2009). Suprasorb X+ PHMB antimicrobial and hydrobalance action in a new wound dressing. Wounds UK 5:72-4.
97. Kirketerp-Møller K, Jensen PØ, Fazli M, et al. (2008). Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 46:2717-22.
98. Kite P, Eastwood K, Percival SL. (2005). Assessing the effectiveness of EDTA formulations for use as a novel catheter lock solution for the eradication of biofilms. In: McBain A, Allison D, Pratten J, et al. Eds. Biofilms, Persistence and Ubiquity, September 6-8th, Bioline, Cardiff, 181-190.
99. Kite P, Eastwood K, Sugden S, Percival SL. (2004). Use of in vivo generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42:3073-6.
100. Kjelleberg S, Molin S. (2002). Is there a role for quorum sensing signals in bacterial biofilms? Curr Opin Microbiol 5:254-8.
101. Körber A, Seipp HM, Hofmann S. (2008). Efficacy of different wound dressings on artificial plaques of fibrin. EWMA J 8:261.
102. Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. (2010). Impact of silvercontaining wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother 54:5120-31.
103. Kramer AA, Müller O, Reichwagen G, et al. (2008). Octenidine, Chlorhexidine, Iodine and Iodophores. Stuttgart, New York: Georg Thieme.
104. Kramer SA. (1999). Effect of povidone-iodine on wound healing: a review. J Vasc Nurs 17:17-23.
105. Kramer A, Roth B, Müller G, et al. (2004). Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets skin. Pharmacol Physiol 17:141-6.
106. Kremer AN, Hoffmann H. (2012). Subtractive hybridization yields a silver resistance determinant unique to nosocomial pathogens in the Enterobacter cloacae complex. J Clin Microbiol 50:3249-57.
107. Kunisada T, Yamada K, Oda S, Hara O. (1997). Investigation of efficacy of PVP-I against antiseptic-resistant species. Dermatol 195:14-18.
108. Lacey RW, Catto A. (1993). Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus. Postgrad Med J 69:578-83.
109. Lambert RJW, Hanlon GW, Denyer SP. (2004). The synergistic effect of EDTA/antimicrobial combinations on Pseudomonas aeruginosa. J Appl Microbiol 96:244-53.
110. Larson EL. (1996). Antiseptics. In: Olmstad RN, ed. APIC infection control & applied epidemiology: principles & practices. St. Louis, MO: Mosby-Year Book, Inc. 1-197.
111. Lavelle KJ, Doedens DJ, Kleit SA, Forney RB. (1975). Iodine absorption in burn patients treated topically with povidone-iodine. Clin Pharmacol Ther 17:355-62.
112. Lawrence JC. (1998). The use of iodine as an antiseptic agent. J Wound Care 7:421-5.
113. Lazarus GS, Cooper DM, Knighton DR, et al. (2002). Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen 2:165-70.
114. Lee TH, Hu CC, Lee SS, et al. (2010). Cytotoxicity of chlorhexidine on human osteoblastic cells is related to intracellular glutathione levels. Int Endod J 43:430-5.
115. Leive L. (1965). Release of lipopolysaccharide by EDTA treatment of E. Coli. Biochem Biophys Res Commun 21:290-6.
116. Lenselink E, Andriessen A. (2011). A cohort study on the efficacy of a polyhexanide-containing biocellulose dressing in the treatment of biofilms in wounds. J Wound Care 20:536-9.
117. Leveen H, Falk G, Borek B, et al. (1973). Chemical acidification of wounds. An adjuvant to healing and the unfavourable action of alkalinity and ammonia. Ann Surgery 178:745-50.
118. Liaqat I, Bachmann RT, Sabri AN, et al. (2010). Isolate-specific effects of patulin, penicillic Acid and EDTA on biofilm formation and growth of dental unit water line biofilm isolates. Curr Microbiol 61: 148-56.
119. Lineaweaver W, Soucy D, Howard R. (1985). Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 75:394-6.
120. Lipp C, Kirker K, Agostinho A, et al. (2010). Testing wound dressings using an in vitro wound model. J Wound Care 19:220-6.
121. Lipsky BA, Hoey C. (2009). Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 49:1541-9.
122. Lu TK, Collins JJ. (2007). Dispersing biofilms with engineered enzymatic bacteriophage. PNAS 104:11197-202.
123. Magrez A, Kasas S, Salicio V, et al. (2006). Cellular toxicity of carbonbased nanomaterials. Nano Lett 6:1121-5.
124. Mangalappalli-Illathu AK, Korber DR. (2006). Adaptive resistance and differential protein expression of Salmonella enterica serovar enteritidis biofilms exposed to benzalkonium chloride. Antimicrob Agents Chemother 50:3588-96.
125. Marbach H, Patel A, Edgeworth JD, Harvey RD. (2013). Effect of antiseptics and environmental pH on membrane phospholipid composition in hospital-associated methicillin-resistant Staphylococcus aureus (MRSA) strains. European Society of Clinical Microbiology and Infectious Disease, Berlin, German 27-30 April 2013. P1397.
126. Martineanu L, Dosch HM. (2007). Biofilm reduction by a new burn gel that targets nociception. J App Microbiol 103:297-304.
127. Matl FD, Zlotnyk J, Obermeier A, et al. (2009). New anti-infective coatings of surgical sutures based on a combination of antiseptics and fatty acids. J Bio Sci 20:10.
128. Mayer DA, Tsapogas MJ. (1993). Povidone-iodine and wound healing: a critical review. Wounds 5:14-23.
129. Mertz PM, Oliviera-Gandia MF, Davis S. (1999). The evaluation of a cadexomer iodine wound dressing on methicillin-resistant Staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg 25:89-93.
130. Mijnendonckx K, Leys N, Mahillon J, et al. (2013). Antimicrobial silver: uses, toxicity and potential for resistance. Biometals 26:609-21.
131. Miller CN, Carville K, Newall N, Kapp S, et al. (2011). Assessing bacterial burden in wounds: comparing clinical observation and wound swabs. Int Wound J 8:45-55.
132. Mitchell BAMH, Skurray RA. (1998). QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanides, and guanylhydrazones. Antimicrob Agents Chemother 42:475-7.
133. Miura T, Tanabe K, Yoshinari M. (2012). Ca (II)-EDTA shows antimicrobial activity against periodontopathic bacteria. J Biomed Sci Eng 5:10-14.
134. Moberg S, Hoffman L, Grennert ML, Holst A. (1983). A randomised trial of cadexomer iodine in decubitus ulcers. J Am Geriatrics Soc 8: 462-5.
135. Monaco JL, Lawrence T. (2003). Acute wound healing: an overview. Clin Plast Surg 30:1-12.
136. Monica S, Favrin S, Romanova N, Griffiths W. (2002). Post adaptational resistance to benzalkonium chloride and subsequent physicochemical modifications of Listeria monocytogenes. Appl Environ Microbiol 68: 5258-64.
137. Moore K, Gray D. (2007). Using PHMB antimicrobial to prevent wound infection. Wounds UK 3:96-102.
138. Moretro T, Hermansen L, Holck AL, et al. (2003). Biofilm formation and the presence of the intercellular adhesion locusica among staphylococci from food and food processing environments. Appl Environ Microbiol 69:5648-55.
139. Motta GJ, Trigilia D. (2005). The effect of an antimicrobial drain sponge dressing on specific bacterial isolates at tracheostomy sites. Ostomy Wound Management 51:60-6.
140. Müller G, Hai DN, Kramer A. (2006). Lack of in vitro genotoxicity of povidone-iodine in solution, in ointment or in a liposomal formulation (Repithel®). Dermatol 212:94-7.
141. Muller G, Kramer A. (2006). Comparative study of in vitro cytotoxicity of povidone-iodine in solution, in ointment or in a liposomal formulation (Repithel®) and selected antiseptics. Dermatol 212:91-3.
142. Muller G, Kramer A. (2008). Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 61:1281-7.
143. Muller S, Vogt PM, Steinau HU, et al. (2006). Repithel: removing the barriers to wound healing. Dermatol 212:77-81.
144. Musk Jr. DJ, Hergenrother PJ. (2006). Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets. Curr Medicinal Chem 13:2163-77.
145. Mycock G. (1985). Methicillin/antiseptic-resistant Staphylococcus aureus. Lancet 2:949-50.
146. Nakamura H, Takakura KI, Sone Y, et al. (2013). Biofilm formation and resistance to benzalkonium chloride in Listeria monocytogenes isolated from a fish processing plant. J Food Protection 76:1179-86.
147. Niedner R. (1997). Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatol 195:89-92.
148. Okkyoung C, Kathy KD, Nam-Jung K, et al. (2008). The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 42:3066-74.
149. O'May CY, Sanderson K, Roddam LF, et al. (2009). Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 58:765-73.
150. Oncag O, Hosgor M, Hilmioglu S, et al. (2003). Comparison of antibacterial and toxic effects of various root canal irrigants. Int Endod J 36:423-32.
151. Path FRC. (1986). Chlorhexidine: antibacterial action and bacterial resistance. Infection 14:212-15.
152. Paulsen IT, Littlejohn TG, Ridstrom P, et al. (1993). The 30 conserved segment of integrons contains a gene associated with multidrup resistance to antiseptics and disinfectants. Antimicrob Agents and Chemother 37:761-8.
153. Payne DN, Babb JR, Bradley CR. (1999). An evaluation of the suitability of the European suspension test to reflect in vitro activity of antiseptics against clinically significant organisms. Lett Appl Microbiol 28:7-12.
154. Percival SL, Bowler P, Woods EJ. (2008). Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 16: 52-7.
155. Percival SL, Bowler PG, Russell D. (2005a). Bacterial resistance to silver in wound care. J Hosp Infect 60:1-7.
156. Percival SL, Dowd S. (2010). Microbiology of acute and chronic wounds. In: Percival SL, Cutting K, eds. Chronic Wounds. Boca Raton, FL: CRC Press, 187-218.
157. Percival SL, Kite P, Eastwood K, et al. (2005b). Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26:515-19.
158. Percival SL, McCarty S, Hunt JA, Woods EJ. (2014). The effects of pH on wound healing, biofilms, and antimicrobial efficacy. Wound Repair Regen 22:174-86.
159. Percival SL, Rogers AA. (2005). The significance and role of biofilms in chronic wounds. In: McBain, A. Et al (eds). Biofilms: Persistence and Ubiquity. Proceedings of the 7th Meeting of the Biofilm Club, Powys, UK, 171-8.
160. Percival SL, Sabbuba NA, Kite P, Stickler DJ. (2009). The effect of EDTA instillations on the rate of development of encrustation and biofilms in Foley catheters. Urol Res 37:205-9.
161. Percival SL, Slone W, Linton S, et al. (2011a). The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates. Int Wound J 8:237-43.
162. Percival SL, Thomas J, Linton S, et al. (2012). The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds. Int Wound J 9:488-93.
163. Percival SL, Thomas JG, Slone W, et al. (2011b). The efficacy of silver dressings and antibiotics on MRSA and MSSA isolated from burn patients. Wound Repair Reg 19:767-74.
164. Percival SL, Thomas JG, Williams DW. (2010a). Biofilms and bacterial imbalances in chronic wounds: anti-Koch. Int Wound J 7: 169-75.
165. Percival SL, Thomas JG, Williams DW. (2010b). The world of microbiology and biofilmology. In Percival SL, Cutting K. Eds. Microbiology of Wounds. Boca Raton, FL: CRC Press, 1-58.
166. Phillips PL, Yang Q, Davis S, Sampson EM, Azeke JI, Hamad A, Schultz GS. (2013a). Antimicrobial dressing efficacy against mature P. Aeruginosa biofilm on porcine skin explants. Int Wound J.
167. Phillips PL, Yang Q, Schultz GS. (2013b). The effect of negative pressure wound therapy with periodic instillation using antimicrobial solutions on Pseudomonas aeruginosa biofilm on porcine skin explants. Int Wound J 10:48-55.
168. Phillips PL, Yang QP, Sampson EM, Schultz GS. (2009). Microbicidal effects of wound dressings on mature bacterial biofilm on porcine skin explants. Poster presented at EWMA.
169. Phillips T, Stanton B, Provan A, Lew R. (1994). A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 31:49-53.
170. Pierard-Franchimont C, Paquet P, Arrese JE, Pierard GE. (1997). Healing rate and bacterial necrotizing vasculitis in venous leg ulcers. Dermatol 194:383-7.
171. Presterl E, Suchomel M, Eder M, et al. (2007). Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 60:417-20.
172. Pucher JJ, Daniel JC. (1992). The effects of chlorhexidine digluconate on human fibroblasts in vitro. J Periodontol 63:526-32.
173. Raad II, Hachem RY, Hanna HA, et al. (2008). Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents 32:515-18.
174. Rabinovitch C, Stewart PS. (2007). Removal and inactivation of Staphylococcus epidermis biofilms by electrolysis. Appl Environmental Microiol 72:6364-6.
175. Radzig MA, Nadtochenko VA, Koksharova OA, et al. (2013). Antibacterial effects of silver nanoparticles on gram-negative bacteria: Influence on the growth and biofilms formation, mechanisms of action. Colloids Surf B 102:300-6.
176. Ramage G, Wickes BL, López-Ribot JL. (2007). Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia 164:301-6.
177. Reimer K, Vogt PM, Broegmann B, et al. (2000). An innovative topical drug formulation for wound healing and infection treatment: in vitro and in vivo investigations of a povidone-iodine liposome hydrogel. Dermatol 201:235-41.
178. Res̈liński A, Dąbrowiecki S, Głowacka K, Szmytkowski J. (2013). The influence of octenidine dihydrochloride on bacterial biofilm on the surface of a polypropylene mesh. Med Biol Sci 27:41-7.
179. Richards RME, Cavill RH. (1976). Electron microscopic study of the effect of benzalkonium chloride and edetate disodium on cell envelope of Pseudomonas aeruginosa. J Pharmacol Sci 65:76-80.
180. Roberts G, Hammad L, Creevy J, et al. (1997). Physical changes in dermal tissues around chronic venous ulcers 7th European conference on advances in wound management. J Wound Manage Assoc 18: 104-5.
181. Rodeheaver GT. (1999). Pressure ulcer debridement and cleansing: a review of current literature. Ostomy/Wound Manage 45:80S-85S.
182. Rodrigues I, Megie M. (2006). Prevalence of chronic wounds in Quebec home care: an exploratory study. Ostomy Wound Manage 52: 46-8.
183. Rojas AI, Phillips TJ. (2001). Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotenes, and zinc. Dermatol Surg 25:601-4.
184. Romanelli M, Schipani E, Piaggesi A, Barachini P. (1997). Evaluation of surface pH on venous leg ulcers under allevyn dressings. London: The Royal Society of Medicine Press.
185. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP. (1998). Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 32:1627-31.
186. Rosenberg A, Alatary SD, Peterson AF. (1976). Safety and efficacy of the antiseptic chlorhexidine gluconate. Surg Gynecol Obstet 143: 789-92.
187. Roshni AMA, Venkitanarayanan K. (2014). Antibiofilm effect of octenidine hydrochloride on Staphylococcus aureus, MRSA and VRSA. Pathogens 3:404-16.
188. Rowbury R. (2011). Miracle molecules of our age: ethylenediaminete-traacetic acid. Sci Prog 94:232-40.
189. Rowe RC, Sheskey PJ, Weller PJ. (2003). Handbook of pharmaceutical excipients. 4th ed. London, UK: The Pharmaceutical Press.
190. Rupf S, Balkenhol M, Sahrhage TO, et al. (2012). Biofilm inhibition by an experimental dental resin composite containing octenidine dihydrochloride. Dent Mater 28:974-84.
191. Russel AD, Hugo WB, Ayliffe GAJ. (1992). Principles and practice of disinfection, preservation and sterilization. 2nd ed. Oxford: Blackwell.
192. Russell AD. (2002a). Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 92: 121-35.
193. Russell AD. (2002b). Mechanisms of antimicrobial action of antiseptics and disinfectants: an increasingly important area of investigation. J Antimicrob Chemother 49:597-9.
194. Russell AD. (2003). Biocide use and antibiotic resistance: the clinical relevance of laboratory findings to clinical and environmental situations. Lancet 3:794-803.
195. Sakagami Y, Yokoyama H, Nishimura H, Tashima T. (1989). Mechanism of resistance to benzalkonium chloride by Pseudomonas aeruginosa. Appl Environ Microbiol 55:2036-40.
196. Schnuch A, Geier J, Uter W, et al. (2007). The biocide polyhexamethylene biguanide remains an uncommon contact allergen. Contact Dermatitis 56:235-9.
197. Schreurs WJ, Rosenberg H. (1982). Effect of silver ions on transport and retention of phosphate by Escherichia coli. J Bacteriol 152:7-13.
198. Selvaggi G, Monstrey S, Van Landuyt K, et al. (2003). The role of iodine in antisepsis and wound management: a reappraisal. Acta Chirurgica Belgica 3:241-7.
199. Sena NT, Gomes BP, Vianna ME, et al. (2006). In vitro antimicrobial activity of sodium hypochlorite and chlorhexidine against selected single-species biofilms. Int Endod J 39:878-85.
200. Sennhenn-Kirchner S, Wolff N, Klaue S, et al. (2009). Decontamination efficacy of antiseptic agents on in vivo grown biofilms on rough titanium surfaces. Quintessence Int 40:80-8.
201. Serralta VW, Harrison-Belestra C, Cazzaniga AL, et al. (2001). Lifestyles of bacteria in wounds: presence of biofilms. Wounds 13: 29-34.
202. Shi CM, Nakao H, Yamazaki M, et al. (2007). Mixture of sugar and povidone-iodine stimulates healing of MRSA-infected skin ulcers on db/db mice. Arch Dermatol Res 299:449-56.
203. Sibbald GR, Woo KY. (2008). The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev 24:S25-30.
204. Silver S, Misra S. (1988). Plasmid-mediated heavy metal resistances. Annu Rev Microbiol 42:711-43.
205. Silver S. (2003). Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27:341-53.
206. Silvestry-Rodriguez N, Sicairos-Ruelas EE, Gerba CP, Bright KR. (2007). Silver as a disinfectant. Rev Environ Contam Toxicol 191: 23-45.
207. Singer AJ, Clark RA. (1999). Cutaneous wound healing. N Engl J Med 341:738-46.
208. Skog E, Arnesjö B, Troëng T, et al. (1983). A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers. Br J Dermatol 109:77.
209. Slone W, Linton S, Okel T, et al. (2011). The effect of pH on the antimicrobial efficiency of silver alginate on chronic wound isolates. J Am Col Certif Wound Spec 2:86-90.
210. Spratt DA, Pratten J, Wilson M, Gulabivala K. (2001). An in vitro evaluation of the antimicrobial efficacy of irrigants on biofilms of root canal isolates. Int Endod J 34:300-7.
211. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. (2010). Topical silver for preventing wound infection. Cochrane Database Syst Rev 17:CD006478.
212. Takahashi N, Fujikawa K, Miyakoshi M, et al. (1992). A flow cytometric study of the effects of benzalkonium chloride on the cell cycle. Nippon Ganka Gakkai Zasshi 96:823-27.
213. Tarbox B, Conroy P, Malicky S, et al. (1998). Benzalkonium chloride: a potential disinfecting irrigation solution for orthopaedic wounds. Clin Orthop 346:255-61.
214. Tatnall FM, Leigh IM, Gibson JR. (1987). Comparative toxicity of anti microbial agents on transformed keratinocytes. J Invest Dermatol 89: 316-17.
215. Thomas JG, Slone W, Linton S, et al. (2011). A comparison of the antimicrobial efficacy of two silver-containing wound dressings on burn wound isolates. J Wound Care 20:580-2.
216. Thorn RM, Austin AJ, Greenman J, et al. (2009). In vitro comparison of antimicrobial activity of iodine and silver dressings against biofilms. J Wound Care 18:343-6.
217. Thorn RMS, Nelson SM, Greenman J. (2007). Use of a bioluminescent pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production. Antimicrob. Agents Chemother 51:3217-24.
218. Tietz A, Frei R, Marc B, et al. (2005). Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect Control Hosp Epidemiol 26:703-7.
219. Tomlinson E, Brown MRW, Davis SS. (1977). Effect of colloidal association on the measured activity of alkylbenzyldimethylammonium chlorides against Pseudomonas aeruginosa. J Med Chem 20: 1277-82.
220. Torlak E, Sert D. (2013). Combined effect of benzalkonium chloride and ultrasound against Listeria monocytogenes biofilm on plastic surface. Lett Appl Microbiol 57:220-6.
221. Toy LW, Macera L. (2011). Evidence-based review of silver dressing use on chronic wounds. J Am Acad Nurse Pract 23:183-92.
222. Trevor JT. (1987). Silver resistance and accumulation in bacteria. Enzyme Microb Technol 9:331-3.
223. Trial C, Darbas H, Lavigne JP, et al. (2010). Assessment of the antimicrobial effectiveness of a new silver alginate wound dressing: a RCT. J Wound Care 19:20-6.
224. Tsukada K, Tokunaga K, Iwama T, Mishima Y. (1992). The pH changes of pressure ulcers related to the healing process of wounds. Wounds 4: 16-20.
225. Ueda S, Kuwabara Y. (2007). Susceptibility of biofilm Escherichia coli, Salmonella enteritidis and Staphylococcus aureus to detergents and sanitizers. Biocontrol Sci 12:149-53.
226. Uygur F, Özyurt M, Evinç R, et al. (2008). Comparison of octenidine dihydrochloride (Octenisept®), polihexanide (Prontosan®) and povidon iodine (Betadine®) for topical antibacterial effects in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. Cent Eur J Med 3:417-21.
227. Van den Broek PJ, Buys LF, Van Furth R. (1982). Interaction of povidone Iodine compounds and phagocytic cells and microorganisms. Antimicrob Agents Chemother 22:593-7.
228. Van de Voorde K, Nijsten T, Schelfhout K, et al. (2005). Long-term use of silver containing nose-drops resulting in systemic argyria. Acta Clin Belg 60:33-5.
229. Veiga DF, Damasceno CA, Veiga Filho J, et al. (2008). Influence of povidone-iodine preoperative showers on skin colonization in elective plastic surgery procedures. Plast Reconstr Surg 121:115-18.
230. Vianna ME, Gomes BP, Berber VB, et al. (2004). In vitro evaluation of the antimicrobial activity of chlorhexidine and sodium hypochlorite. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:79-84.
231. Viljanto J. (1980). Disinfection of surgical wounds without inhibition of normal wound healing. Archives of Surgery 115:253-6.
232. Vogt PM, Hauser J, Robbach O, et al. (2001). Polyvinyl pyrrolidoneiodine liposome hydrogel improves epithelialization by combining moisture and antisepis. A new concept in wound therapy. Wound Repair Regen 9:116-22.
233. Wagner KH, Jürss A, Zarembach B, Elmadfa I. (2004). Impact of antiseptics on radical metabolism, antioxidant status and genotoxic stress in blood cells: povidone-iodine versus octenidine dihydrochloride. Toxicol in Vitro 18:411-18.
234. Weeke J. (2000). Chapter 41: thyroid and anti-thyroid drugs. In: Dukes, MNG, Aronson JK, eds. Meyler's side effects of drugs. 14th ed. Amsterdam: Elsevier Science BV; 1492-3.
235. Werthen M, Davoudi M, Sonesson A, et al. (2004). Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J Antimicrob Chemother 54:772-9.
236. Westgate S, Cutting K. (2011). The role of microbial biofilms in chronic and acute wounds. Nurs Residential Care 13:518-21.
237. Wiegand C, Abel M, Ruth P, Hipler UC. (2009). HaCaT keratinocytes in co-culture with Staphylococcus aureus can be protected from bacterial damage by polihexanide. Wound Repair Regen 17:730-8.
238. Willenborg SKJ, Ranjan R, Krieg T, Eming SA. (2010). Chronic wounds and inflammation. Advances in wound care. New Rochelle, NY: Mary Ann Liebert, 259-65.
239. Wilson M, Henry M, Quill R, Byrne P. (1979). The pH of varicose ulcer surfaces and its relationship to healing. VASA 8:339-42.
240. Woodcock PM, Heatley F, Gilbert P. (1984). Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli. J Appl Bacteriol 57:115-24.
241. Wu MY, Suryanarayanan K, van Ooij, WJ, Oerther DB. (2007). Using microbial genomics to evaluate the effectiveness of silver to prevent biofilm formation. Water Sci Technol 55:413-19.
242. Wutzler P, Sauerbrei A, Klöcking R, et al. (2002). Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res 54:89-97.
243. Xavier JB, Picioreanu C, Rani SA, et al. (2005). Biofilm-control strategies based on enzymic disruption of the extracellular polymeric substance matrix - a modelling study. Microbiol 151:3817-32.
244. Yager DR, Nwomeh BC. (2002). The proteolytic environment of chronic wounds. Wound Repair Regen 7:433-41.
245. Zamora JL. (1986). Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 151:400-6.
246. Zhou LH, Nahm WK, Badiavas E, et al. (2002). Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br J Dermatol 146:365-74.